fructose 2,6-diphosphate has been researched along with Astrocytoma, Grade IV in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartrons, R; Castaño, E; Fontova, P; Manzano, A; Martinez-Outshoorn, U; Navarro-Sabaté, À; Rodríguez-García, A; Rosa, JL; Samsó, P; Simon-Molas, H; Ventura, F | 1 |
Chen, Q; Ding, Z; Du, L; Guo, W; Jiang, T; Lee, JH; Li, J; Li, XJ; Liu, R; Lorenzi, PL; Lu, Z; Mills, GB; Qian, X; Tan, L; Wang, Y; Xia, Y; Xu, D; Zhang, C; Zheng, Y | 1 |
2 other study(ies) available for fructose 2,6-diphosphate and Astrocytoma, Grade IV
Article | Year |
---|---|
TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
Topics: Cell Proliferation; Fructosediphosphates; Glioblastoma; Glucose; Glycolysis; Humans; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphofructokinase-2; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2017 |
EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.
Topics: Acetylation; Adaptor Proteins, Signal Transducing; Animals; Brain Neoplasms; Cell Line, Tumor; Class Ia Phosphatidylinositol 3-Kinase; Enzyme Activation; ErbB Receptors; Feedback, Physiological; Fructosediphosphates; Glioblastoma; Glucose Transporter Type 1; Glycolysis; Humans; Lysine Acetyltransferase 5; Male; Mice, Inbred BALB C; Mice, Nude; Phosphatidylinositol 3-Kinases; Phosphofructokinase-1, Type C; Phosphofructokinase-2; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-akt; Signal Transduction; src Homology Domains | 2018 |